Homoeopathic versus conventional therapy for atopic eczema in children: medical and economic results.
Standard
Homoeopathic versus conventional therapy for atopic eczema in children: medical and economic results. / Witt, Claudia M; Brinkhaus, Benno; Pach, Daniel; Reinhold, Thomas; Wruck, Katja; Roll, Stephanie; Jäckel, Tanja; Staab, Doris; Wegscheider, Karl; Willich, Stefan N.
In: DERMATOLOGY, Vol. 219, No. 4, 4, 2009, p. 329-340.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Homoeopathic versus conventional therapy for atopic eczema in children: medical and economic results.
AU - Witt, Claudia M
AU - Brinkhaus, Benno
AU - Pach, Daniel
AU - Reinhold, Thomas
AU - Wruck, Katja
AU - Roll, Stephanie
AU - Jäckel, Tanja
AU - Staab, Doris
AU - Wegscheider, Karl
AU - Willich, Stefan N
PY - 2009
Y1 - 2009
N2 - BACKGROUND: One of five children visiting a homoeopathic physician is suffering from atopic eczema. OBJECTIVE: To examine the effectiveness, safety and costs of homoeopathic versus conventional treatment in usual care. METHODS: In a prospective multicentre comparative observational non-randomised study, 135 children (homoeopathy n = 48 vs. conventional n = 87) with mild to moderate atopic eczema were included. The primary outcome was the SCORAD (Scoring Atopic Dermatitis) at 6 months. Further outcomes at 6 and 12 months also included quality of life of parents and children, use of conventional medicine, treatment safety and disease-related costs. RESULTS: The adjusted SCORAD showed no significant differences between the groups at both 6 months (homoeopathy 22.49 + or - 3.02 [mean + or - SE] vs. conventional 18.20 + or - 2.31, p = 0.290) and 12 months (17.41 + or - 3.01 vs. 17.29 + or - 2.31, p = 0.974). Adjusted costs were higher in the homoeopathic than in the conventional group: for the first 6 months EUR 935.02 vs. EUR 514.44, p = 0.026, and for 12 months EUR 1,524.23 vs. EUR 721.21, p = 0.001. Quality of life was not significantly different between both groups. Conclusion: Taking patient preferences into account, homoeopathic treatment was not superior to conventional treatment for children with mild to moderate atopic eczema.
AB - BACKGROUND: One of five children visiting a homoeopathic physician is suffering from atopic eczema. OBJECTIVE: To examine the effectiveness, safety and costs of homoeopathic versus conventional treatment in usual care. METHODS: In a prospective multicentre comparative observational non-randomised study, 135 children (homoeopathy n = 48 vs. conventional n = 87) with mild to moderate atopic eczema were included. The primary outcome was the SCORAD (Scoring Atopic Dermatitis) at 6 months. Further outcomes at 6 and 12 months also included quality of life of parents and children, use of conventional medicine, treatment safety and disease-related costs. RESULTS: The adjusted SCORAD showed no significant differences between the groups at both 6 months (homoeopathy 22.49 + or - 3.02 [mean + or - SE] vs. conventional 18.20 + or - 2.31, p = 0.290) and 12 months (17.41 + or - 3.01 vs. 17.29 + or - 2.31, p = 0.974). Adjusted costs were higher in the homoeopathic than in the conventional group: for the first 6 months EUR 935.02 vs. EUR 514.44, p = 0.026, and for 12 months EUR 1,524.23 vs. EUR 721.21, p = 0.001. Quality of life was not significantly different between both groups. Conclusion: Taking patient preferences into account, homoeopathic treatment was not superior to conventional treatment for children with mild to moderate atopic eczema.
M3 - SCORING: Zeitschriftenaufsatz
VL - 219
SP - 329
EP - 340
JO - DERMATOLOGY
JF - DERMATOLOGY
SN - 1018-8665
IS - 4
M1 - 4
ER -
